October 11, 2024 /

Webinar: SHIELD DMD – A Bone Health Study in Duchenne

Bone health is an important aspect of living with Duchenne muscular dystrophy. Roche recently joined PPMD for a webinar during which Maitea Guridi, a Principal Clinical Scientist at Roche, shared learnings around the natural history of bone health in Duchenne. We also discussed why fractures occur and how the SHIELD study will explore the potential of satralizumab to target both bone health and muscle function in Duchenne.


Join Our Mailing List